110 related articles for article (PubMed ID: 17875783)
21. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
[TBL] [Abstract][Full Text] [Related]
22. Different temporal expression of immunodominant Ro60/60 kDa-SSA and La/SSB apotopes.
Reed JH; Neufing PJ; Jackson MW; Clancy RM; Macardle PJ; Buyon JP; Gordon TP
Clin Exp Immunol; 2007 Apr; 148(1):153-60. PubMed ID: 17286801
[TBL] [Abstract][Full Text] [Related]
23. Cross-recognition between histones and La/SSB may account for anti-DNA reactivity in SLE patients.
Touloupi E; Routsias JG; Tzioufas AG
Clin Exp Immunol; 2005 Oct; 142(1):172-9. PubMed ID: 16178873
[TBL] [Abstract][Full Text] [Related]
24. DNA-dependent protein kinase (DNA-PK)-dependent cisplatin-induced loss of nucleolar facilitator of chromatin transcription (FACT) and regulation of cisplatin sensitivity by DNA-PK and FACT.
Dejmek J; Iglehart JD; Lazaro JB
Mol Cancer Res; 2009 Apr; 7(4):581-91. PubMed ID: 19372586
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy combined to cisplatin potentiates cell death responses of cervical cancer cells.
de Freitas LM; Serafim RB; de Sousa JF; Moreira TF; Dos Santos CT; Baviera AM; Valente V; Soares CP; Fontana CR
BMC Cancer; 2017 Feb; 17(1):123. PubMed ID: 28187758
[TBL] [Abstract][Full Text] [Related]
26. Ammonium chloride enhances cisplatin cytotoxicity through DNA double-strand breaks in human cervical cancer cells.
Xu Y; Wang N; Ding Y; Wang C; Yu Y; Liu S; Wang X; Li Z
Oncol Rep; 2013 Sep; 30(3):1195-200. PubMed ID: 23783842
[TBL] [Abstract][Full Text] [Related]
27. Amifostine can differentially modulate DNA double-strand breaks and apoptosis induced by idarubicin in normal and cancer cells.
Wozniak K; Gloc E; Morawiec Z; Blasiak J
Exp Oncol; 2008 Mar; 30(1):22-8. PubMed ID: 18438337
[TBL] [Abstract][Full Text] [Related]
28. Secondary necrosis is a source of proteolytically modified forms of specific intracellular autoantigens: implications for systemic autoimmunity.
Wu X; Molinaro C; Johnson N; Casiano CA
Arthritis Rheum; 2001 Nov; 44(11):2642-52. PubMed ID: 11710720
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.
Dogra S; Bandi S; Viswanathan P; Gupta S
Cancer Lett; 2015 Jan; 356(2 Pt B):953-61. PubMed ID: 25444910
[TBL] [Abstract][Full Text] [Related]
30. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
31. Detection of apoptosis-specific autoantibodies directed against granzyme B-induced cleavage fragments of the SS-B (La) autoantigen in sera from patients with primary Sjögren's syndrome.
Huang M; Ida H; Kamachi M; Iwanaga N; Izumi Y; Tanaka F; Aratake K; Arima K; Tamai M; Hida A; Nakamura H; Origuchi T; Kawakami A; Ogawa N; Sugai S; Utz PJ; Eguchi K
Clin Exp Immunol; 2005 Oct; 142(1):148-54. PubMed ID: 16178869
[TBL] [Abstract][Full Text] [Related]
32. Exposure and binding of selected immunodominant La/SSB epitopes on human apoptotic cells.
Neufing PJ; Clancy RM; Jackson MW; Tran HB; Buyon JP; Gordon TP
Arthritis Rheum; 2005 Dec; 52(12):3934-42. PubMed ID: 16320341
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.
Chen CS; Wang YC; Yang HC; Huang PH; Kulp SK; Yang CC; Lu YS; Matsuyama S; Chen CY; Chen CS
Cancer Res; 2007 Jun; 67(11):5318-27. PubMed ID: 17545612
[TBL] [Abstract][Full Text] [Related]
34. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
Ohga T; Koike K; Ono M; Makino Y; Itagaki Y; Tanimoto M; Kuwano M; Kohno K
Cancer Res; 1996 Sep; 56(18):4224-8. PubMed ID: 8797596
[TBL] [Abstract][Full Text] [Related]
35. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
36. Preferential targeting of apoptosis in tumor versus normal cells.
Woynarowska BA; Woynarowski JM
Biochim Biophys Acta; 2002 Jul; 1587(2-3):309-17. PubMed ID: 12084473
[TBL] [Abstract][Full Text] [Related]
37. Is cisplatin-induced cell death always produced by apoptosis?
Gonzalez VM; Fuertes MA; Alonso C; Perez JM
Mol Pharmacol; 2001 Apr; 59(4):657-63. PubMed ID: 11259608
[TBL] [Abstract][Full Text] [Related]
38. The autoantigen La/SSB: detection on and uptake by mitotic cells.
Bachmann M; Zaubitzer T; Müller WE
Exp Cell Res; 1992 Aug; 201(2):387-98. PubMed ID: 1639136
[TBL] [Abstract][Full Text] [Related]
39. Candidate T cell epitopes of the human La/SSB autoantigen.
Davies ML; Taylor EJ; Gordon C; Young SP; Welsh K; Bunce M; Wordsworth BP; Davidson B; Bowman SJ
Arthritis Rheum; 2002 Jan; 46(1):209-14. PubMed ID: 11817592
[TBL] [Abstract][Full Text] [Related]
40. Induction and repair of DNA double-strand breaks using constant-field gel electrophoresis and apoptosis as predictive markers for sensitivity of cancer cells to cisplatin.
Saleh EM; El-Awady RA; Anis N; El-Sharkawy N
Biomed Pharmacother; 2012 Oct; 66(7):554-62. PubMed ID: 22939736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
